Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

Premium Phosphosite-Specific 7TM Antibodies

Phosphorylation of intracellular serine and threonine residues is the most important post translational modification of G protein-coupled receptors (GPCRs) also called heptahelical or seven transmembrane receptors (7TMR). After agonist exposure, these receptors acquire an active conformation, which is recognized by a family of highly specialized GPCR kinases (GRKs). Agonist-driven phosphorylation by GRKs regulates acute receptor desensitization, arrestin recruitment, internalization, post-activation signaling, long-term tolerance and drug addiction. Phosphosite-specific 7TM antibodies are designed to specifically detect agonist-activated GPCRs. In fact, recent work shows that ligand profiling using phosphosite-specific 7TM antibodies provides valuble information on ligand bias beyond that obtained with conventional ß-arrestin recruitment assays. Phosphosite-specific 7TM antibodies are novel tools for GPCR research that can be used to:

  • profile agonist properties of novel GPCR ligands
  • decipher the phosphorylation barcode of GPCRs
  • determine the spatial and temporal dynamics of receptor phosphorylation
  • identify relevant kinases and phosphatases for GPCR phosphorylation and dephosphoryation

Lifecycle3

Schematic representation of the G protein-coupled receptor phosphorylation / dephosphorylation cycle. GRK, G protein-coupled receptor kinase; PKC, protein kinase C; cPP1, catalytic subunit of protein phosphatase 1; R*, activated GPCR; CCP, clathrin-coated pit. 

Close filters
35 From 38
No results were found for the filter!
Citations
NEW
KO-Validated
Immunohistochemical Identification of Agonist-induced Threonine376 phosphorylation of the µ-Opioid Receptor in mouse spinal cord
pT376-MOP (IHC-grade phospho-µ-Opioid Receptor...
Threonine376 (T376) is a major phosphorylation site of the µ-opioid receptor (MOP). The pT376-MOP antibody detects phosphorylation in response to high-efficacy agonists but to low-efficacy agonists or after PKC activation. T376...
$ 500.00 *
Details
Citations
NEW
KO-Validated
Immunohistochemical Identification of Agonist-induced Threonine379 phosphorylation of the µ-Opioid Receptor in mouse spinal cord
pT379-MOP (IHC-grade phospho-µ-Opioid Receptor...
Threonine379 (T379) is a major phosphorylation site of the µ-opioid receptor (MOP). The pT379-MOP antibody detects phosphorylation in response to high-efficacy agonists but to low-efficacy agonists or after PKC activation. T379...
$ 500.00 *
Details
Citations
KO-Validated
Immunohistochemical identification of Bradykinin Receptor 2 in pancreatic islets
B2 (IHC-grade), Bradykinin Receptor 2 Antibody
The B2 receptor antibody is directed against the distal part of the carboxyl-terminal tail of human B2. It can be used to detect total B2 receptors in Western blots independent of phosphorylation. The B2 antibody can also be used to...
$ 375.00 *
Details
NEW
Immunohistochemical identification of FFA4 Receptor in human spleen
FFA4 (IHC-grade), FFA4 Receptor Antibody
The FFA4 receptor antibody is directed against the distal part of the carboxyl-terminal tail of human FFA4. It can be used to detect total FFA4 receptors in Western blots independent of phosphorylation. The FFA4 antibody can also be used...
$ 375.00 *
Details
NEW
Immunohistochemical identification of Serine 425/Serine429 phosphorylation of VPAC2 Receptor in mouse brain suprachiasmatic nucleus.
pS425/pS429-VPAC2 (IHC grade phospho-VIP...
Serine425/Serine429 (S425/S429) is a major phosphorylation site of the VPAC2 receptor. The pS425/pS429-VPAC2 antibody detects phosphorylation in response to high-efficacy agonists. S425/S429 phosphorylation is a key regulator of VPAC2...
$ 500.00 *
Details
NEW
Immunohistochemical identification of APLN Receptor in human pancreas
APLNR (IHC-grade), Apelin Receptor Antibody
The non-phospho-APLNR antibody is directed against the distal end of the carboxyl-terminal tail of human apelin receptor. It also detects APLNR in cultured cells and tissue sections by immunohistochemistry. It can be used to detect total...
$ 375.00 *
Details
NEW
Detection of non-phosphorylated human FFA4 Receptor
FFA4 (non-phospho-FFA4 Antibody)
The non-phospho-FFA4 receptor antibody is directed against the distal part of the carboxyl-terminal tail of human FFA4. It can be used to detect total FFA4 receptors in Western blots independent of phosphorylation. The non-phospho-FFA4...
$ 375.00 *
Details
NEW
Validation of the GPR15 Receptor in transfected HEK293 cells
GPR15 (non-phospho), G protein-coupled Receptor...
The non-phospho-GPR15 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR15. It can be used to detect total GPR15 receptors in Western blots independent of phosphorylation. The GPR15 antibody...
$ 375.00 *
Details
NEW
Validation of the GPR26 Receptor in transfected HEK293 cells
GPR26 (non-phospho), G protein-coupled Receptor...
The non-phospho-GPR26 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR26. It can be used to detect total GPR26 receptors in Western blots independent of phosphorylation. The GPR26 antibody...
$ 375.00 *
Details
NEW
Validation of the GPR34 Receptor in transfected HEK293 cells
GPR34 (non-phospho), G protein-coupled Receptor...
The non-phospho-GPR34 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR34. It can be used to detect total GPR34 receptors in Western blots independent of phosphorylation. The GPR34 antibody...
$ 375.00 *
Details
NEW
Validation of the GPR39 Receptor in transfected HEK293 cells
GPR39 (non-phospho), G protein-coupled Receptor...
The non-phospho-GPR39 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR39. It can be used to detect total GPR39 receptors in Western blots independent of phosphorylation. The GPR39 antibody...
$ 375.00 *
Details
NEW
Validation of the GPR97/ADGR3G Receptor in transfected HEK293 cells
GPR97/ADGRG3 (non-phospho), G protein-coupled...
The non-phospho-GPR97/ADGRG3 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR97/ADGRG3. It can be used to detect total GPR97/ADGRG3 receptors in Western blots independent of phosphorylation....
$ 375.00 *
Details
NEW
Validation of the GPR101 Receptor in transfected HEK293 cells
GPR101 (non-phospho), G protein-coupled...
The non-phospho-GPR101 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR101. It can be used to detect total GPR101 receptors in Western blots independent of phosphorylation. The GPR101...
$ 375.00 *
Details
NEW
Validation of the GPR31 Receptor in transfected HEK293 cells
GPR31 (non-phospho), G protein-coupled...
The non-phospho-GPR31 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR31. It can be used to detect total GPR3 receptors in Western blots independent of phosphorylation. The GPR31 antibody...
$ 375.00 *
Details
NEW
Validation of the OXE Receptor in transfected HEK293 cells.
OXER (non-phospho), Oxoeicosanoid Receptor...
The non-phospho-OXE receptor antibody is directed against the distal end of the carboxyl-terminal tail of human OXER. It can be used to detect total OXE receptors in Western blots independent of phosphorylation. The OXER antibody can...
$ 375.00 *
Details
NEW
Validation of the M2 Muscarinic Acetylcholine Receptor in transfected HEK293 cells
M2 (non-phospho-M2 Muscarinic Acetylcholine...
The non-phospho-M2 receptor antibody is directed against the 3rd loop of human M2 Muscarinic Acetylcholine Receptor (M2). It can be used to detect total M2 receptors in Western blots independent of phosphorylation. The non-phospho-M2...
$ 375.00 *
Details
35 From 38

For further reading refer to:

Kliewer A, Reinscheid RK, Schulz S. Emerging Paradigms of G Protein-Coupled Receptor Dephosphorylation. Trends Pharmacol Sci. 2017 Jul;38(7):621-636. doi:10.1016/j.tips.2017.04.002. Epub 2017 May 4. Review. PubMed PMID: 28478994.

Miess E, Gondin AB, Yousuf A, Steinborn R, Mösslein N, Yang Y, Göldner M, Ruland JG, Bünemann M, Krasel C, Christie MJ, Halls ML, Schulz S, Canals M. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization. Sci Signal. 2018 Jul 17;11(539). pii: eaas9609. doi: 10.1126/scisignal.aas9609. PubMed PMID: 30018083.

Kliewer A, Schmiedel F, Sianati S, Bailey A, Bateman JT, Levitt ES, Williams JT, Christie MJ, Schulz S. Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects. Nat Commun. 2019 Jan 21;10(1):367. doi: 10.1038/s41467-018-08162-1. PubMed PMID: 30664663; PubMed Central PMCID: PMC6341117.

Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Sci Signal. 2019 Mar 26;12(574). pii: eaau8072. doi: 10.1126/scisignal.aau8072. PubMed PMID: 30914485; PubMed Central PMCID: PMC6934085.

Saaber F, Schütz D, Miess E, Abe P, Desikan S, Ashok Kumar P, Balk S, Huang K, Beaulieu JM, Schulz S, Stumm R. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin. Cell Rep. 2019 Feb 5;26(6):1473-1488.e9. doi: 10.1016/j.celrep.2019.01.049. PubMed PMID: 30726732.

Glück L, Loktev A, Moulédous L, Mollereau C, Law PY, Schulz S. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5. Biol Psychiatry. 2014 Nov 15;76(10):767-74. doi: 10.1016/j.biopsych.2014.01.021. Epub 2014 Feb 3. PubMed PMID: 24629717; PubMed Central PMCID: PMC4119866.

For further reading refer to: Kliewer A, Reinscheid RK, Schulz S. Emerging Paradigms of G Protein-Coupled Receptor Dephosphorylation. Trends Pharmacol Sci. 2017 Jul;38(7):621-636.... read more »
Close window
Premium Phosphosite-Specific 7TM Antibodies

For further reading refer to:

Kliewer A, Reinscheid RK, Schulz S. Emerging Paradigms of G Protein-Coupled Receptor Dephosphorylation. Trends Pharmacol Sci. 2017 Jul;38(7):621-636. doi:10.1016/j.tips.2017.04.002. Epub 2017 May 4. Review. PubMed PMID: 28478994.

Miess E, Gondin AB, Yousuf A, Steinborn R, Mösslein N, Yang Y, Göldner M, Ruland JG, Bünemann M, Krasel C, Christie MJ, Halls ML, Schulz S, Canals M. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization. Sci Signal. 2018 Jul 17;11(539). pii: eaas9609. doi: 10.1126/scisignal.aas9609. PubMed PMID: 30018083.

Kliewer A, Schmiedel F, Sianati S, Bailey A, Bateman JT, Levitt ES, Williams JT, Christie MJ, Schulz S. Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects. Nat Commun. 2019 Jan 21;10(1):367. doi: 10.1038/s41467-018-08162-1. PubMed PMID: 30664663; PubMed Central PMCID: PMC6341117.

Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Sci Signal. 2019 Mar 26;12(574). pii: eaau8072. doi: 10.1126/scisignal.aau8072. PubMed PMID: 30914485; PubMed Central PMCID: PMC6934085.

Saaber F, Schütz D, Miess E, Abe P, Desikan S, Ashok Kumar P, Balk S, Huang K, Beaulieu JM, Schulz S, Stumm R. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin. Cell Rep. 2019 Feb 5;26(6):1473-1488.e9. doi: 10.1016/j.celrep.2019.01.049. PubMed PMID: 30726732.

Glück L, Loktev A, Moulédous L, Mollereau C, Law PY, Schulz S. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5. Biol Psychiatry. 2014 Nov 15;76(10):767-74. doi: 10.1016/j.biopsych.2014.01.021. Epub 2014 Feb 3. PubMed PMID: 24629717; PubMed Central PMCID: PMC4119866.

Recently viewed